Back to News
Market Impact: 0.1
Daxor to Showcase Blood Volume Analysis Platform at ASN Kidney Week 2026
Source: globenewswire.com
Healthcare & BiotechProduct LaunchesTechnology & Innovation
Daxor is making its ASN debut with its BVA™ technology, which the company says provides precise volume measurement to support fluid management and complex kidney care. Daxor will exhibit at Booth #390 during ASN Kidney Week 2026 in Denver, October 21–25; the article provides no performance data or financial figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
DXR0.40
More News
- South Korean carmaker Hyundai plans 'strategic' investment of $15.5 billion in India by 2032
- Applied Materials’ $5 billion AI lab aims to cut chip development time in half—and restore Silicon Valley’s edge
- Meta’s Muse models reach the AI frontier—and kill any hopes to ‘pace’ it
- Mainspring, AEP Strike Deal to Bring Power Online Faster
- Why this little known Chinese chipmaker has caused a global stock rout
- Applied Materials CEO on Doubling Revenue Thanks To AI
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Tools for CFA Charterholders: An Evidence Standard
- Weekly Update: Unstructured Data Search, Ask AI, and Advanced Futures Data